A number of different serious side effects have come to light in relation to a popular cancer treatment known as Tasigna. Chief among these are Tasigna circulation problems.

It might take time for some patients taking the drug to realize they are experiencing Tasigna circulation problems. Some who have complained to their doctors report that they were not told about the risk of circulation issues and didn’t know the symptoms to be aware of and to share with their doctor.

Tasigna circulation problems could lead to the diagnosis of atherosclerosis. Atherosclerosis is the narrowing, hardening or clogging of the arteries and over time. Ultimately, this can restrict blood flow to important locations in the body.

Tasigna circulation problems can also develop into peripheral arterial disease.

Many of the reports related to Tasigna circulation problems claim that neither patients nor doctors were adequately warned about the dangerous risks of this medication and the possibility of developing side effects. The development of Tasigna circulation problems could lead to more significant medical conditions if they are not caught quickly.

If plaque buildup from atherosclerosis becomes inflamed or brittle, this can cause a blood clot to form. In the event that Tasigna circulation problems develop, gangrene and limb amputation might be the only ways for the person to recover from circulation problems affecting the feet or the legs.

In addition to Tasigna circulation problems, patients have reported concerns over stroke, infection, heart attack, atherosclerosis, the development of coronary artery disease, circulatory issues throughout the body, amputation, and death.

In 2007, Tasigna was first approved by the FDA for treating patients with chronic myeloid leukemia. As it is one of the most popular cancer drugs in the world, many of the consumers who have experienced Tasigna circulation problems are frustrated that they were never told about these risks prior to taking the medication. Although Tasigna was approved with a black box warning related to other side effects, some patients claim they were not told about the possibility of Tasigna circulation problems or atherosclerosis for several years following the drug’s placement on the market.

A growing number of lawsuits accuse the company of being aware of the risk of side effects, including Tasigna circulation problems, but waiting several years before notifying patients by putting an update on the label.

If you or someone you know has already experienced Tasigna circulation problems, you may qualify for a free Tasigna atherosclerosis lawsuit investigation.